A Crack In Creation: A Nobel Prize Winner's Insight into the Future of Genetic Engineering

by Jennifer A. Doudna

New studies surface at a rate of more than five per day, on average, and investors have poured well over a billion dollars into the various startup companies that are pursuing CRISPR-based biotechnology tools and medical therapeutics.